Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Gujarat Inject (Kerala)'s current ratio for the quarter that ended in Jun. 2026 was 0.00.
Gujarat Inject (Kerala) has a current ratio of 0.00. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Gujarat Inject (Kerala) has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Gujarat Inject (Kerala)'s Current Ratio or its related term are showing as below:
BOM:524238'
s Current Ratio Range Over the Past 10 Years
Min: 0.02 Med: 0.08 Max: 62.04
Current: 0.47
During the past 12 years, Gujarat Inject (Kerala)'s highest Current Ratio was 62.04. The lowest was 0.02. And the median was 0.08.
BOM:524238's Current Ratio is ranked worse than 91.07% of 1411
companies
in the Biotechnology industry
Industry Median: 3.88
vs BOM:524238: 0.47
Gujarat Inject (Kerala) (BOM:524238) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Gujarat Inject (Kerala) Current Ratio Related Terms
Gujarat Inject (Kerala) Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524238 vs VRTX, REGN, ALNY: Current Ratio Comparison
For the Biotechnology subindustry, Gujarat Inject (Kerala)'s Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gujarat Inject (Kerala) Current Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gujarat Inject (Kerala)'s Current Ratio distribution charts can be found below:
* The bar in red indicates where Gujarat Inject (Kerala)'s Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gujarat Inject (Kerala) (BOM:524238) has a Current Ratio of 0.00 as of Jun. 2026. Over the past decade, Gujarat Inject (Kerala)'s Current Ratio has ranged from 0.02 to 62.04. According to the industry distribution chart, Gujarat Inject (Kerala) ranks #1285 out of 1411 companies in the Biotechnology industry, placing it in the top 91.1%.
Is Gujarat Inject (Kerala)'s Current Ratio too high?
Gujarat Inject (Kerala)'s current Current Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 62.04. Based on the distribution chart, Gujarat Inject (Kerala) ranks #1285 out of 1411 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Gujarat Inject (Kerala) has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gujarat Inject (Kerala)'s Current Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gujarat Inject (Kerala) ranks #1285 out of 1411 companies for Current Ratio. This places Gujarat Inject (Kerala) in the lower half of its industry. The industry median Current Ratio is 3.88. Historically, Gujarat Inject (Kerala)'s own Current Ratio has ranged from 0.02 to 62.04 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.88, based on 1,411 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gujarat Inject (Kerala)'s current Current Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Inject (Kerala) stock overvalued right now?
Based on GuruFocus' analysis, Gujarat Inject (Kerala) (BOM:524238) is currently considered Fairly Valued. The stock's GF Value™ is ₹10.82, compared to a current price of ₹11.40 — trading 5.4% above its estimated fair value. The current Current Ratio is 0.00. Gujarat Inject (Kerala)'s overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Gujarat Inject (Kerala) (BOM:524238), the current Current Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gujarat Inject (Kerala) (BOM:524238) Overvalued in 2026?
Based on GuruFocus' analysis, Gujarat Inject (Kerala) stock appears to be overvalued.
The current stock price of ₹11.40 is trading 5.4% above its estimated GF Value™ of ₹10.82.
GuruFocus considers Gujarat Inject (Kerala) to be Fairly Valued.
Key valuation signals for BOM:524238:
Current Ratio: 0.00
GF Value™: ₹10.82 vs. price of ₹11.40 (5.4% above fair value)
No single metric tells the full story. See the BOM:524238 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524238 has been successfully added to your 
